Lasmiditan
Records for this ingredient, by country (identity only).
ATC N02CC08 · 5 markets · 8 records
JP 2 records · 2 shown of 2
- 100 mgtabletレイボー錠100mg
- 50 mgtabletレイボー錠100mg
ES 1 records · 1 shown of 1
- 100 mgtabletRAYVOW
EU 1 records · 0 shown of 0
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
| Strength / form / release | US | ES | JP | EU |
|---|---|---|---|---|
| 100 mg tablet | Reyvow | RAYVOW | レイボー錠100mg | |
| 50 mg tablet | Reyvow | レイボー錠100mg | ||
unknown | RAYVOW |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
1 more strength/form rows are recorded only in EU and are not shown in this table. Hay 1 filas de concentración/forma registradas solo en EU que no se muestran en esta tabla. 另有 1 个规格/剂型仅在 EU 有记录（未在本表显示）。 另有 1 個規格/劑型僅在 EU 有記錄（未在本表顯示）。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.